|
BX10602 |
4-[4-[2-[3-(3,4-dimethoxyphenyl)-5-thiophen-2-yl-3,4-dihydropyrazol-2-yl]-1,3-thiazol-4-yl]phenyl]sulfonylmorpholine |
421581-07-9 |
C28H28N4O5S3 |
596.7407 |
VIEW DETAILS > |
|
BS20546 |
2-[3-(furan-2-yl)-5-(4-methoxyphenyl)-3,4-dihydropyrazol-2-yl]-4-(4-piperidin-1-ylsulfonylphenyl)-1,3-thiazole |
421581-10-4 |
C28H28N4O4S2 |
548.6763 |
VIEW DETAILS > |
|
BX22674 |
5-[[3-bromo-4-[(3-nitrophenyl)methoxy]phenyl]methylidene]-1,3-diazinane-2,4,6-trione |
421581-21-7 |
C18H12BrN3O6 |
446.2084 |
VIEW DETAILS > |
|
BW99420 |
ethyl 2-benzyl-3-oxo-3-(thiazol-2-ylamino)propanoate |
421581-47-7 |
C15H16N2O3S |
304.3641 |
VIEW DETAILS > |
|
BT94421 |
9-(allylthio)-8-ethyl-5,6-dihydronaphtho[2',1':4,5]thieno[2,3-d]pyrimidin-7(8H)-one |
421581-50-2 |
C19H18N2OS2 |
354.4890 |
VIEW DETAILS > |
|
BS76788 |
4-chloro-N-[2-(5-phenylmethoxy-1H-indol-3-yl)ethyl]benzamide |
421581-51-3 |
C24H21ClN2O2 |
404.8887 |
VIEW DETAILS > |
|
BF09515 |
G6PD activator AG1 |
421581-52-4 |
C24H30N4S2 |
438.6518 |
VIEW DETAILS > |
|
BT50336 |
2-[2-(5-methoxy-1H-indol-3-yl)ethyl]-3a,4,5,6,7,7a-hexahydroisoindole-1,3-dione |
421581-53-5 |
C19H22N2O3 |
326.3896 |
VIEW DETAILS > |
|
BT71892 |
3-(4-chlorophenyl)-5-hydroxy-5-(trifluoromethyl)-4H-pyrazole-1-carboxamide |
421581-56-8 |
C11H9ClF3N3O2 |
307.6563 |
VIEW DETAILS > |
|
AF60910 |
5-(4-Fluorophenyl)-3-(3-nitrophenyl)-1,2,4-oxadiazole |
421581-70-6 |
C14H8FN3O3 |
285.2300 |
VIEW DETAILS > |